According to this criterion, 87 (38%) of colon cancer samples showed a strong positive staining, 129 (56%) showed a weak staining, whereas 15 (6%) samples stained altogether negative for TRAIL-R1 (Figure 1). Here, TNFRSF10A is linked to malignant colon neoplasm.